Clal Insurance’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$150M Sell
346,052
-9
-0% -$2.73K 0.67% 35
2026
Q1
$74M Sell
346,061
-202,939
-37% -$45.4M 0.45% 48
2025
Q4
$94.1M Sell
549,000
-369,000
-40% -$57.4M 0.61% 38
2025
Q3
$123M Buy
918,000
+48,000
+6% +$5.08M 0.94% 29
2025
Q2
$84.9M Sell
870,000
-660,000
-43% -$52.3M 0.83% 33
2025
Q1
$112M Buy
+1,530,000
New +$120M 1.15% 20
2024
Q2
Sell
-555,000
Closed -$54M 140
2024
Q1
$54M Buy
555,000
+170,000
+44% +$15M 0.61% 42
2023
Q4
$30.2M Buy
+385,000
New +$26.2M 0.4% 56

Other funds holding LRCX

Clal Insurance's LRCX Position: Q2 2026 in Review

Clal Insurance reduced its Lam Research (LRCX) stake by 0% in Q2 2026, selling an estimated $2.73K and leaving 346,052 shares worth $150M. The position accounts for 0.67% of the portfolio, ranked #35.

Clal Insurance first reported a position in LRCX in Q4 2023 and has held it in 8 quarters since. 3,118 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Clal Insurance held 346,052 shares of Lam Research worth $150M as of Q2 2026.
  • Clal Insurance sold 9 Lam Research shares in Q2 2026, an estimated $2.73K.
  • Lam Research made up 0.67% of Clal Insurance's portfolio in Q2 2026, its #35 holding.
  • Clal Insurance first reported a position in Lam Research in Q4 2023 and has held it in 8 quarters since.
  • 3,118 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Clal Insurance's 13F filing for Q2 2026, filed 13 Aug 2026.